FMP
MyMD Pharmaceuticals, Inc.
MYMD
NASDAQ
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore, Maryland.
2.58 USD
0.08 (3.1%)
About
ceo
Dr. Christopher C. Chapman Jr., M.D.
sector
Healthcare
industry
Biotechnology
website
https://www.mymd.com
exchange
NASDAQ
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore...
CIK
0001321834
ISIN
US62856X2018
CUSIP
00973E409
Address
855 North Wolfe Street
Phone
856 848 8698
Country
US
Employee
6
IPO Date
Jan 23, 2014
Summary
CIK
0001321834
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
00973E409
ISIN
US62856X2018
Country
US
Price
2.58
Beta
3.17
Volume Avg.
226.41k
Market Cap
5.57M
Shares
-
52-Week
2.0-70.5
DCF
1.71
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.48
P/B
-
Website
https://www.mymd.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest MYMD News
It looks like there's no news available.
